ClearBridge Investments
SRPT icon

ClearBridge Investments’s Sarepta Therapeutics SRPT Stock Holding History

ClearBridge Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-145,230
Closed -$9.27M – 736
2025
Q1 		$9.27M Sell
145,230
-91,848
-39% -$9.67M 0.01% 498
2024
Q4 		$28.8M Buy
237,078
+1
+0% +$123 0.02% 395
2024
Q3 		$29.6M Sell
237,077
-277
-0.1% -$38.3K 0.02% 398
2024
Q2 		$37.5M Buy
237,354
+86,138
+57% +$11.1M 0.03% 368
2024
Q1 		$19.6M Buy
151,216
+89
+0.1% +$10.9K 0.02% 462
2023
Q4 		$14.6M Buy
+151,127
New +$14.5M 0.01% 508

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

ClearBridge Investments's SRPT Position: Q2 2025 in Review

ClearBridge Investments sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 145,230 shares — an estimated $9.27M sold.

ClearBridge Investments first reported a position in SRPT in Q4 2023 and held it in 6 quarters. The position peaked at $37.5M in Q2 2024. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • ClearBridge Investments reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • ClearBridge Investments sold 145,230 Sarepta Therapeutics shares in Q2 2025, an estimated $9.27M.
  • ClearBridge Investments first reported a position in Sarepta Therapeutics in Q4 2023 and held it in 6 quarters.
  • ClearBridge Investments's Sarepta Therapeutics position peaked at $37.5M in Q2 2024.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on ClearBridge Investments's 13F filing for Q2 2025, filed 12 Aug 2025.